Phase I/II trial of linvoseltamab in R/R MM produces positive pivotal data

UAMS receives $10.5M NIH grant to develop biomarkers through proteomics

The University of Arkansas for Medical Sciences received a $10.5 million NIH grant to develop biomarkers for all human diseases, including cancer, through proteomics.

December 05, 2025

Vol.51 No.44

In Brief

UAMS Cancer Institute director Michael Birrer inducted into American Academy of Sciences and Letters

Michael J. Birrer, director of the Winthrop P. Rockefeller Cancer Institute at the University of Medical Sciences, has been inducted as a member of the American Academy of Sciences and Letters.

November 21, 2025

Vol.51 No.43

In Brief

UAMS Winthrop P. Rockefeller Cancer Institute, ARcare partner to boost CRC screenings in rural Arkansas

A new partnership between the University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute and ARcare aims to improve colorectal cancer screening rates in seven rural Arkansas counties where late-stage diagnoses and cancer disparities are on the rise.

July 25, 2025

Vol.51 No.29

In Brief

Fenghuang “Frank” Zhan invested in inaugural Bart Barlogie Chair for Myeloma Research

The University of Arkansas for Medical Sciences College of Medicine invested Fenghuang “Frank” Zhan, a tenured professor of medicine and the research director of the UAMS Winthrop P. Rockefeller Cancer Institute’s Myeloma Center, in the Bart Barlogie Chair for Myeloma Research during a March 13 ceremony.

March 21, 2025

Vol.51 No.11

In Brief

Matteo Paz wins 2025 Regeneron Science Talent Search

Matteo Paz, 18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s longest-running and most distinguished science, technology, engineering, and math competition for high school seniors (The Cancer Letter, March 7, 2025).

March 14, 2025

Vol.51 No.10